Clinical Trial: A Study of RBI-4000 in Healthy Participants
Study Status: Completed
Recruit Status: RECRUITING
Condition: Healthy Volunteers
Study Type: INTERVENTIONAL
Official Title: A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of RBI-4000 in Healthy Volunteers
Brief Summary:
The primary purpose of the study is to evaluate the safety, reactogenicity, and immunogenicity of RBI-4000 administered at various dose levels via intramuscular injection and to determine the lowest dose of RBI-4000 necessary to elicit the rabies virus neutralizing antibody titer of equal or greater than (>=) 0.5 international unit per milliliter (IU/mL).
Read more